Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ying-Wei Li, Jin Guo, He Shen, Jun Li, Nuo Yang, Costa Frangou, Kayla E. Wilson, Yinglong Zhang, Ashley L. Mussell, Marius Sudol, Amjad Farooq, Jun Qu & Jianmin Zhang. (2016) Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation. Cell Cycle 15:18, pages 2497-2505.
Read now
Read now
Articles from other publishers (39)
Brooke L. Brauer, Kwame Wiredu, Scott A. Gerber & Arminja N. Kettenbach. (2022) Evaluation of Quantification and Normalization Strategies for Phosphoprotein Phosphatase Affinity Proteomics: Application to Breast Cancer Signaling. Journal of Proteome Research 22:1, pages 47-61.
Crossref
Crossref
He Shen, Yuwen Zhang, Elliot D. Kramer, Eriko Katsuta, Yin Wan, Yanmin Chen, Jianmin Wang, Yali Zhang, Junko Matsuzaki, Costa Frangou, Scott I. Abrams & Jianmin Zhang. (2022) Loss-of-function of the hippo transducer TAZ reduces mammary tumor growth through a myeloid-derived suppressor cell-dependent mechanism. Cancer Gene Therapy 29:11, pages 1791-1800.
Crossref
Crossref
Dai Cao, Die Chen, Jiang-Nan Xia, Wen-Yan Wang, Guo-Yuan Zhu, Li-Wen Chen, Chuantao Zhang, Bo Tan, Hui Li & Ying-Wei Li. (2022) Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation. Biomedicine & Pharmacotherapy 155, pages 113705.
Crossref
Crossref
Hirotoshi Soyama, Miki Nishio, Junji Otani, Toshiko Sakuma, Shintaro Takao, Shigeo Hara, Takaaki Masuda, Koshi Mimori, Shinya Toyokuni, John P. Lydon, Kazuwa Nakao, Hiroshi Nishina, Takumi Fukumoto, Tomohiko Maehama & Akira Suzuki. (2022) Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers. Proceedings of the National Academy of Sciences 119:29.
Crossref
Crossref
Hassan Yousefi, Mahsa Rostamian Delavar, Fatemeh Piroozian, Masoud Baghi, Khoa Nguyen, Thomas Cheng, Cecilia Vittori, David Worthylake & Suresh K. Alahari. (2022) Hippo signaling pathway: A comprehensive gene expression profile analysis in breast cancer. Biomedicine & Pharmacotherapy 151, pages 113144.
Crossref
Crossref
Francesca Paradiso, Stefania Lenna, S. Andrea Gazze, Jezabel Garcia Parra, Kate Murphy, Lavinia Margarit, Deyarina Gonzalez, Lewis Francis & Francesca Taraballi. (2022) Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer. Cells 11:5, pages 824.
Crossref
Crossref
Lu Yang, Bo Wang, Xinyan Jiao, Can Zhou, Su Chen, Xiaoqian Gao, Wei Sun, Shaoran Song, Juan Li, Jie Liu, Yaochun Wang & Peijun Liu. (2021) TAZ maintains telomere length in TNBC cells by mediating Rad51C expression. Breast Cancer Research 23:1.
Crossref
Crossref
Jing Chen, Runlan Wan, Qinqin Li, Zhenghuan Rao, Yanlin Wang, Lei Zhang & Alexander Tobias Teichmann. (2021) Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer. Cancer Cell International 21:1.
Crossref
Crossref
Mian Xie, Xin-ge Fu & Ke Jiang. (2021) Notch1/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer. Cell Death & Disease 12:9.
Crossref
Crossref
He Shen, Yanmin Chen, Yin Wan, Tao Liu, Jianmin Wang, Yali Zhang, Lei Wei, Qiang Hu, Bo Xu, Mikhail Chernov, Costa Frangou & Jianmin Zhang. (2021) Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Suman Mohajan, Praveen Kumar Jaiswal, Mousa Vatanmakarian, Hassan Yousefi, Saikolappan Sankaralingam, Suresh K. Alahari, Sweaty Koul & Hari K. Koul. (2021) Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer. Cancer Letters 507, pages 112-123.
Crossref
Crossref
Jie Liu, Gang Zhao, Xin-Li Liu, Ge Zhang, Shi-Qi Zhao, Shi-Long Zhang, Li-Heng Luo, Da-Chuan Yin & Chen-Yan Zhang. (2021) Progress of non-coding RNAs in triple-negative breast cancer. Life Sciences 272, pages 119238.
Crossref
Crossref
Nadia Flores-Huerta, Macrina B. Silva-Cázares, Lourdes A. Arriaga-Pizano, Jessica L. Prieto-Chávez & César López-Camarillo. (2021) LncRNAs and microRNAs as Essential Regulators of Stemness in Breast Cancer Stem Cells. Biomolecules 11:3, pages 380.
Crossref
Crossref
Ayyoob Khosravi, Seyyed Mehdi Jafari & Jahanbakhsh Asadi. (2021) Knockdown of TAZ decrease the cancer stem properties of ESCC cell line YM-1 by modulation of Nanog, OCT-4 and SOX2. Gene 769, pages 145207.
Crossref
Crossref
Wenxia Zhao, Mengyan Wang, Meilian Cai, Conghui Zhang, Yuhan Qiu, Xiaowei Wang, Tianshu Zhang, Huimin Zhou, Junxia Wang, Wuli Zhao & Rongguang Shao. (2021) Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer. Biomedicine & Pharmacotherapy 133, pages 110956.
Crossref
Crossref
Tara Fresques & Mark A. LaBarge. (2020) Contributions of Yap and Taz dysfunction to breast cancer initiation, progression, and aging‐related susceptibility. Aging and Cancer 1:1-4, pages 5-18.
Crossref
Crossref
Giovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, Silvia Paccagnella, Valentina Carraro, Rocco Cappellesso, Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Marcello Lo Mele & Matteo Fassan. (2020) The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies. International Journal of Molecular Sciences 21:21, pages 8102.
Crossref
Crossref
Ashley Mussell, He Shen, Yanmin Chen, Michalis Mastri, Kevin H. Eng, Wiam Bshara, Costa Frangou & Jianmin Zhang. (2020) USP1 Regulates TAZ Protein Stability Through Ubiquitin Modifications in Breast Cancer. Cancers 12:11, pages 3090.
Crossref
Crossref
Dai Cao, Guo-Yuan Zhu, Yan Lu, Aiping Yang, Die Chen, Hui-Jie Huang, Shu-Xian Peng, Li-Wen Chen & Ying-Wei Li. (2020) Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity. Biomedicine & Pharmacotherapy 129, pages 110462.
Crossref
Crossref
Xi-ping Zhang, Qi-hui Cheng, Hong-jian Yang & En-qi Qiao. (2018) Research Progresses in Cancer Stem Cells of Three Common Fertility-Related Female Malignancies. Pathology & Oncology Research 25:3, pages 827-835.
Crossref
Crossref
Richard Harrop, Eric O’Neill & Peter L. Stern. (2019) Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen. Therapeutic Advances in Vaccines and Immunotherapy 7, pages 251513551882162.
Crossref
Crossref
He Shen, Nuo Yang, Alexander Truskinovsky, Yanmin Chen, Ashley L. Mussell, Norma J. Nowak, Lester Kobzik, Costa Frangou & Jianmin Zhang. (2019) Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis. Molecular Cancer Research 17:1, pages 250-262.
Crossref
Crossref
Abrar Jamous & Zaidoun Salah. (2018) WW-Domain Containing Protein Roles in Breast Tumorigenesis. Frontiers in Oncology 8.
Crossref
Crossref
Ying-Wei Li, Jian Xu, Guo-Yuan Zhu, Zhu-Juan Huang, Yan Lu, Xian-Qian Li, Neng Wang & Feng-Xue Zhang. (2018) Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity. Cell Death Discovery 4:1.
Crossref
Crossref
Shengfeng Wang, Dezheng Huo, Temidayo O. Ogundiran, Oladosu Ojengbede, Wei Zheng, Katherine L. Nathanson, Barbara Nemesure, Stefan Ambs, Olufunmilayo I. Olopade & Yonglan Zheng. (2018) Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry. Molecular Carcinogenesis 57:10, pages 1311-1318.
Crossref
Crossref
Amir Kedan, Nandini Verma, Ashish Saroha, Michal Shreberk-Shaked, Anna-Katharina Müller, Nishanth Ulhas Nair & Sima Lev. (2018) PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein. Cell Death & Disease 9:10.
Crossref
Crossref
Judy Crabtree & Lucio Miele. (2018) Breast Cancer Stem Cells. Biomedicines 6:3, pages 77.
Crossref
Crossref
Michael D. Deel, Katherine K. Slemmons, Ashley R. Hinson, Katia C. Genadry, Breanne A. Burgess, Lisa E.S. Crose, Nina Kuprasertkul, Kristianne M. Oristian, Rex C. Bentley & Corinne M. Linardic. (2018) The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis. Clinical Cancer Research 24:11, pages 2616-2630.
Crossref
Crossref
Kayla E. Denson, Ashley L. Mussell, He Shen, Alexander Truskinovsky, Nuo Yang, Natesh Parashurama, Yanmin Chen, Costa Frangou, Fajun Yang & Jianmin Zhang. (2018) The Hippo Signaling Transducer TAZ Regulates Mammary Gland Morphogenesis and Carcinogen-induced Mammary Tumorigenesis. Scientific Reports 8:1.
Crossref
Crossref
Han-Byul Kim & Seung-Jae Myung. (2018) Clinical implications of the Hippo-YAP pathway in multiple cancer contexts. BMB Reports 51:3, pages 119-125.
Crossref
Crossref
Víctor Mayoral-Varo, Annarica Calcabrini, María Pilar Sánchez-Bailón & Jorge Martín-Pérez. (2017) miR205 inhibits stem cell renewal in SUM159PT breast cancer cells. PLOS ONE 12:11, pages e0188637.
Crossref
Crossref
Yinglong Zhang, He Shen, Henry G. Withers, Nuo Yang, Kayla E. Denson, Ashley L. Mussell, Alexander Truskinovsky, Qingyu Fan, Irwin H. Gelman, Costa Frangou & Jianmin Zhang. (2017) VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer. Scientific Reports 7:1.
Crossref
Crossref
Jihang Yu, Adel Alharbi, Hongchao Shan, Yawei Hao, Brooke Snetsinger, Michael J Rauh & Xiaolong Yang. (2017) TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1. Oncotarget 8:24, pages 38426-38443.
Crossref
Crossref
Chuanwei Yang, Xuemei Zhao, Naipeng Cui & Yulong Liang. (2017) Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast Cancer. Stem Cells International 2017, pages 1-13.
Crossref
Crossref
Jianmin Zhang, Song Yao, Qiang Hu, Qianqian Zhu, Song Liu, Kathryn L. Lunetta, Stephen A. Haddad, Nuo Yang, He Shen, Chi-Chen Hong, Lara Sucheston-Campbell, Edward A. Ruiz-Narvaez, Jeannette T. Bensen, Melissa A. Troester, Elisa V. Bandera, Lynn Rosenberg, Christopher A. Haiman, Andrew F. Olshan, Julie R. Palmer & Christine B. Ambrosone. (2016) Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium. Carcinogenesis 37:10, pages 951-956.
Crossref
Crossref
Francesca Zanconato, Michelangelo Cordenonsi & Stefano Piccolo. (2016) YAP/TAZ at the Roots of Cancer. Cancer Cell 29:6, pages 783-803.
Crossref
Crossref
Marcello Maugeri-Saccà & Ruggero De Maria. (2016) Hippo pathway and breast cancer stem cells. Critical Reviews in Oncology/Hematology 99, pages 115-122.
Crossref
Crossref
Lauren J. Manderfield, Haig Aghajanian, Kurt A. Engleka, Lillian Y. Lim, Feiyan Liu, Rajan Jain, Li Li, Eric N. Olson & Jonathan A. Epstein. (2015) Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest. Development 142:17, pages 2962-2971.
Crossref
Crossref
Marcello Maugeri-Saccà, Maddalena Barba, Laura Pizzuti, Patrizia Vici, Luigi Di Lauro, Rosanna Dattilo, Ilio Vitale, Monica Bartucci, Marcella Mottolese & Ruggero De Maria. (2015) The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications. Expert Reviews in Molecular Medicine 17.
Crossref
Crossref